Optimistic about the future - Executive Director bei BeOne: Mitarbeiterbewertung

5,0
9. Juli 2025
Empfehlen
CEO-Befürwortung
Geschäftsprognose

Pros

Very nice and collaborative colleagues across the world. Have not run into any 'back-stabbers' yet, which is refreshing. Company very much lives its mission of eradicating cancer. Benefits are fantastic (best I've ever had, which is in comparison to multiple big pharmas I've worked for). High ambition to push the envelope, do things differently, and grow into a best-in-class biotech organization.

Kontras

Information flow still tends to be 'person to person' via relationships rather than governance which can make things extremely inefficient. Company is (rightfully) being disciplined about costs/expenses, so many functions are running very lean (while at the same time working inefficiently but with high appetite for doing more). Company is evolving into a global organization, but there is still resistance from key players to keep it as a 'China' and 'everyone else' setup...which again makes work efforts inefficient. Depending on role, work hours are long to cover global time zones (and the US employees tend to flex hours to fit the China time zone, rather than the other way around).

avatar
Reaktion von BeOne
10mo
Thank you for posting your review. We will make sure your comments are shared with the proper departments. We are always looking to improve the experience for our employees. We appreciate the five star review.

Mehr Bewertungen zu BeOne entdecken

5,0
24. Apr. 2026
Mitarbeiter (anonym)
Empfehlen
CEO-Befürwortung
Geschäftsprognose

Pros

BeOne Medicines is building a strong reputation as a global oncology-focused company with a patient-centered approach. They’ve demonstrated the ability to advance innovative therapies across both hematologic malignancies and solid tumors, while also expanding their global footprint in clinical development. Their collaborative culture and emphasis on scientific rigor make them a compelling organization to work with and learn from.

Kontras

Fast timelines and global expansion may translate into heavy workload and urgency

3,0
5. Juni 2026
Empfehlen
CEO-Befürwortung
Geschäftsprognose

Pros

Good wprk tee lunch and free commute

Kontras

Bad work but bad commute to work

Bewertungen anzeigen nach: Hilfreich|Sterne|Datum|Alle